BTWM
CVS icon

Baker Tilly Wealth Management’s CVS Health CVS Stock Holding History

Baker Tilly Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
12,135
-1,298
-10% -$116K 0.27% 62
2026
Q1 		$965K Buy
13,433
+196
+1% +$15.1K 0.23% 85
2025
Q4 		$1.05M Sell
13,237
-61
-0.5% -$4.81K 0.26% 76
2025
Q3 		$1M Sell
13,298
-270
-2% -$18.5K 0.23% 89
2025
Q2 		$936K Buy
13,568
+471
+4% +$30.9K 0.33% 66
2025
Q1 		$887K Buy
+13,097
New +$784K 0.35% 69
2024
Q4 		– Sell
-4,595
Closed -$289K – 239
2024
Q3 		$289K Sell
4,595
-3,808
-45% -$222K 0.13% 184
2024
Q2 		$496K Sell
8,403
-9,065
-52% -$567K 0.2% 121
2024
Q1 		$1.39M Buy
17,468
+406
+2% +$31K 0.25% 92
2023
Q4 		$1.35M Sell
17,062
-3,030
-15% -$216K 0.22% 104
2023
Q3 		$1.4M Sell
20,092
-940
-4% -$66.6K 0.23% 92
2023
Q2 		$1.45M Buy
21,032
+4,638
+28% +$330K 0.15% 143
2023
Q1 		$1.22M Buy
16,394
+1,471
+10% +$123K 0.14% 170
2022
Q4 		$1.39M Sell
14,923
-390
-3% -$37.6K 0.17% 134
2022
Q3 		$1.46M Buy
15,313
+622
+4% +$61.6K 0.2% 107
2022
Q2 		$1.36M Sell
14,691
-190
-1% -$18.5K 0.18% 123
2022
Q1 		$1.51M Sell
14,881
-584
-4% -$61.4K 0.17% 127
2021
Q4 		$1.59M Buy
15,465
+2,097
+16% +$194K 0.17% 122
2021
Q3 		$1.13M Buy
13,368
+1,809
+16% +$152K 0.15% 142
2021
Q2 		$964K Buy
11,559
+1,325
+13% +$109K 0.16% 152
2021
Q1 		$770K Buy
10,234
+404
+4% +$29.4K 0.16% 165
2020
Q4 		$671K Buy
+9,830
New +$639K 0.21% 113

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

Baker Tilly Wealth Management's CVS Position: Q2 2026 in Review

Baker Tilly Wealth Management reduced its CVS Health (CVS) stake by 9.7% in Q2 2026, selling an estimated $116K and leaving 12,135 shares worth $1.26M. The position accounts for 0.27% of the portfolio, ranked #62.

Baker Tilly Wealth Management first reported a position in CVS in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.59M in Q4 2021. 546 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Baker Tilly Wealth Management held 12,135 shares of CVS Health worth $1.26M as of Q2 2026.
  • Baker Tilly Wealth Management sold 1,298 CVS Health shares in Q2 2026, an estimated $116K.
  • CVS Health made up 0.27% of Baker Tilly Wealth Management's portfolio in Q2 2026, its #62 holding.
  • Baker Tilly Wealth Management first reported a position in CVS Health in Q4 2020 and has held it in 22 quarters since.
  • Baker Tilly Wealth Management's CVS Health position peaked at $1.59M in Q4 2021.
  • 546 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.